SC
NVNO

Sepio Capital’s enVVeno Medical NVNO Stock Holding History

Sepio Capital’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-309
Closed -$55.1K – 359
2022
Q4 		$55.1K Hold
309
– – ﹤0.01% 336
2022
Q3 		$68K Hold
309
– – 0.01% 318
2022
Q2 		$41K Buy
+309
New +$47.9K ﹤0.01% 329

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return

Sepio Capital's NVNO Position: Q1 2023 in Review

Sepio Capital sold out of enVVeno Medical (NVNO) in Q1 2023, closing a stake of 309 shares — an estimated $55.1K sold.

Sepio Capital first reported a position in NVNO in Q2 2022 and held it in 3 quarters. The position peaked at $68K in Q3 2022. 18 funds tracked by Wall St. Rank hold NVNO as of Q1 2023.

  • Sepio Capital reported no remaining enVVeno Medical position as of Q1 2023 after selling out during the quarter.
  • Sepio Capital sold 309 enVVeno Medical shares in Q1 2023, an estimated $55.1K.
  • Sepio Capital first reported a position in enVVeno Medical in Q2 2022 and held it in 3 quarters.
  • Sepio Capital's enVVeno Medical position peaked at $68K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2023.

Based on Sepio Capital's 13F filing for Q1 2023, filed 10 May 2023.